The Benefits of Neuroids /Neuropeptides in Combating , Neurological, and Ocular Diseases.

Article ID

045L1

The Benefits of Neuroids /Neuropeptides in Combating , Neurological, and Ocular Diseases.

Ishaq Khan
Ishaq Khan
DOI

Abstract

Neuroids and neuropeptides (ND/NPs) are drugs with promising efficacy in cerebrovascular diseases. In this article the benefits and mechanisms of action of ND/NPs for stroke are reviewed in light of the pathogenesis of stroke. The primary mechanism is that ND/NPs help in the synthesis of acetylcholine and betaine. These, in turn, work to help in the formation of nerve cell membrane phospholipids and attenuate the production of free radicals. This is important in stroke because brain damage after stroke is associated with excess production of free radicals. Furthermore, ND/NPs may stimulate the activity of glutathione reductase and have the ability to promote learning and improve cognitive impairment. Pharmacokinetics suggests that ND/NPs are well absorbed, with a higher degree of bioavailability when administered orally. A dose of 500 mg to 2,000 mg per day in slow releasing form is an effective regimen based on clinical trials, and is safe for use in elderly population and pediatrics.

The Benefits of Neuroids /Neuropeptides in Combating , Neurological, and Ocular Diseases.

Neuroids and neuropeptides (ND/NPs) are drugs with promising efficacy in cerebrovascular diseases. In this article the benefits and mechanisms of action of ND/NPs for stroke are reviewed in light of the pathogenesis of stroke. The primary mechanism is that ND/NPs help in the synthesis of acetylcholine and betaine. These, in turn, work to help in the formation of nerve cell membrane phospholipids and attenuate the production of free radicals. This is important in stroke because brain damage after stroke is associated with excess production of free radicals. Furthermore, ND/NPs may stimulate the activity of glutathione reductase and have the ability to promote learning and improve cognitive impairment. Pharmacokinetics suggests that ND/NPs are well absorbed, with a higher degree of bioavailability when administered orally. A dose of 500 mg to 2,000 mg per day in slow releasing form is an effective regimen based on clinical trials, and is safe for use in elderly population and pediatrics.

Ishaq Khan
Ishaq Khan

No Figures found in article.

Ishaq Khan. 2017. “. Global Journal of Medical Research – A: Neurology & Nervous System GJMR-A Volume 17 (GJMR Volume 17 Issue A1): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Classification
GJMR-A Classification: NLMC Code: WL 358.5, WL 302, WW 410
Keywords
Article Matrices
Total Views: 3429
Total Downloads: 1705
2026 Trends
Research Identity (RIN)
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

The Benefits of Neuroids /Neuropeptides in Combating , Neurological, and Ocular Diseases.

Ishaq Khan
Ishaq Khan

Research Journals